CIK 0001087294 · Non-accelerated filer<br>Smaller reporting company
CUMBERLAND PHARMACEUTICALS INC
Sign in to watch- Ticker
- CPIX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- TN
- Entity type
- operating
- EIN
- 621765329
- Phone
- 615-255-0068
- Business address
- 1600 WEST END AVENUE, SUITE 1300, NASHVILLE,, TN, 37203
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 71 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-03-17 | Galante Joseph C Director | Grant or award | +1,000 | $5.17 | $5K | 61,856 |
| 2025-03-17 | Brown Martin S JR Director | Grant or award | +1,000 | $5.17 | $5K | 8,500 |
| 2025-03-17 | Herman James L VP and Chief Compliance Office | Grant or award · Options (right to buy) | +2,500 | $5.17 | $13K | 18,500 |
| 2025-03-17 | Bitterman Chris T. Vice Pres Sales & Marketing | Grant or award · Options (right to buy) | +2,750 | $5.17 | $14K | 16,000 |
| 2025-03-17 | Anthony Todd M. Vice Pres Organizational Dev | Grant or award · Options (right to buy) | +3,000 | $5.17 | $16K | 18,000 |
| 2025-03-17 | KAZIMI A J Chairman and CEO | Shares withheld for taxes | −3,558 | $5.17 | $18K | 5,698,738 |
| 2025-03-17 | KAZIMI A J Chairman and CEO | Grant or award · Options (right to buy) | +100,000 | $5.17 | $517K | 468,000 |
| 2025-03-17 | Hamm John M. VP Chief Financial Officer | Grant or award · Options (right to buy) | +2,750 | $5.17 | $14K | 15,250 |
| 2025-03-16 | Hamm John M. VP Chief Financial Officer | Shares withheld for taxes | −5,930 | $5.46 | $32K | 20,073 |
| 2025-03-14 | Young Caroline Director | Purchase 10b5-1 | +3 | $5.38 | $16 | 32,353 |
| 2025-03-14 | Jones James Director | Purchase 10b5-1 | +7 | $5.38 | $38 | 42,731 |
| 2025-03-14 | KAZIMI A J Chairman and CEO | Purchase 10b5-1 | +7 | $5.38 | $38 | 5,698,823 |
| 2025-03-14 | Krogulski Kenneth Director | Purchase 10b5-1 | +37 | $5.38 | $199 | 283,263 |
| 2025-03-13 | Young Caroline Director | Purchase 10b5-1 | +3 | $5.47 | $16 | 32,350 |
| 2025-03-13 | Jones James Director | Purchase 10b5-1 | +7 | $5.47 | $38 | 42,724 |
| 2025-03-13 | KAZIMI A J Chairman and CEO | Purchase 10b5-1 | +7 | $5.47 | $38 | 5,698,816 |
| 2025-03-13 | Krogulski Kenneth Director | Purchase 10b5-1 | +37 | $5.47 | $202 | 283,226 |
| 2025-03-12 | Young Caroline Director | Purchase 10b5-1 | +3 | $5.17 | $16 | 32,347 |
| 2025-03-12 | Jones James Director | Purchase 10b5-1 | +7 | $5.17 | $36 | 42,717 |
| 2025-03-12 | KAZIMI A J Chairman and CEO | Purchase 10b5-1 | +7 | $5.17 | $36 | 5,698,809 |
Page 42 of 207 · 4,129 trades